本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

康乃德生物醫藥

0.8212
-0.0078-0.94%
成交量:10.17萬
成交額:8.17萬
市值:4,545.28萬
市盈率:-2.90
高:0.8464
開:0.8229
低:0.7500
收:0.8290
資料載入中...
2025/04/01

重要事件披露

Form 8-K - Current report
2025/03/31

重要事件披露

Form 8-K - Current report
2025/03/31

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/07/01

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/04/16

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/27

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/27

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/13

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/20

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/14

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/04

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities